FR3031902B1 - Composition de complement alimentaire apres intervention medicale pour traiter l’obesite - Google Patents

Composition de complement alimentaire apres intervention medicale pour traiter l’obesite

Info

Publication number
FR3031902B1
FR3031902B1 FR1550658A FR1550658A FR3031902B1 FR 3031902 B1 FR3031902 B1 FR 3031902B1 FR 1550658 A FR1550658 A FR 1550658A FR 1550658 A FR1550658 A FR 1550658A FR 3031902 B1 FR3031902 B1 FR 3031902B1
Authority
FR
France
Prior art keywords
supplements
composition
medical intervention
treat obesity
obesity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1550658A
Other languages
English (en)
Other versions
FR3031902A1 (fr
Inventor
Jean Michel Verd
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Horuscare
Original Assignee
Horuscare
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Horuscare filed Critical Horuscare
Priority to FR1550658A priority Critical patent/FR3031902B1/fr
Publication of FR3031902A1 publication Critical patent/FR3031902A1/fr
Application granted granted Critical
Publication of FR3031902B1 publication Critical patent/FR3031902B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/733—Fructosans, e.g. inulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Child & Adolescent Psychology (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR1550658A 2015-01-28 2015-01-28 Composition de complement alimentaire apres intervention medicale pour traiter l’obesite Expired - Fee Related FR3031902B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR1550658A FR3031902B1 (fr) 2015-01-28 2015-01-28 Composition de complement alimentaire apres intervention medicale pour traiter l’obesite

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1550658A FR3031902B1 (fr) 2015-01-28 2015-01-28 Composition de complement alimentaire apres intervention medicale pour traiter l’obesite

Publications (2)

Publication Number Publication Date
FR3031902A1 FR3031902A1 (fr) 2016-07-29
FR3031902B1 true FR3031902B1 (fr) 2017-01-13

Family

ID=52824464

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1550658A Expired - Fee Related FR3031902B1 (fr) 2015-01-28 2015-01-28 Composition de complement alimentaire apres intervention medicale pour traiter l’obesite

Country Status (1)

Country Link
FR (1) FR3031902B1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL2019348B3 (en) * 2017-07-26 2019-09-05 Ams Advanced Medical Supplements B V Pharmaceutical composition for use in the treatment or prevention of vitamin deficiency and mineral deficiency in patients who have been subjected to gastric sleeve surgery

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070116802A1 (en) * 2005-11-23 2007-05-24 Carl Germano High quality caloric composition
WO2009153064A2 (fr) * 2008-06-19 2009-12-23 N.V. Nutricia Composition nutritionnelle liquide destinée à des patients ayant subi une chirurgie bariatrique
CN104187624B (zh) * 2014-08-07 2016-06-08 逯明福 综合营养粉及其制备方法

Also Published As

Publication number Publication date
FR3031902A1 (fr) 2016-07-29

Similar Documents

Publication Publication Date Title
IL264626A (en) A preparation for the prevention or treatment of diseases related to il-8
IL257978B (en) Using pasteurized acremnesia to treat metabolic diseases
MA43135A (fr) Compositions et méthodes pour le du traitement du cancer
PT3212233T (pt) Terapia combinada para o tratamento de doenças
IL247942A0 (en) Compositions and methods for drops in macular edema as a result of diabetes
IL275321A (en) Treatment of diseases associated with the expression of DUX4
HK1247931A1 (zh) 用於診斷和治療癌症的組合物和方法
HUE054828T2 (hu) Eljárások és készítmények a bél enteroendokrin rendszerének stimulálására a vele kapcsolatos betegségek és állapotok kezelésére
ZA201702884B (en) Compositions and methods for the treatment and prophylaxis of surgical site infections
HK1258994A1 (zh) 用於疾病治療的方法
IL248210A0 (en) Methods and preparations for the treatment of blood vessel malformations
LU92643B1 (fr) Composition comestible pour le traitement de la phase de début du syndrome dépressif
IL259710A (en) Preparations and methods for the treatment of Davidson's disease (microvillus inclusion disease) and related diseases
FR3022139B1 (fr) Nouvelles compositions pour le traitement des rougeurs cutanees et de la rosacee
GB201612043D0 (en) Composition for treatment of disorders
PL3233074T3 (pl) Leczenie niealkoholowych stłuszczeniowych chorób wątroby
IL256919A (en) Pharmaceutical compositions useful for the treatment of tissue damage
FR3031902B1 (fr) Composition de complement alimentaire apres intervention medicale pour traiter l’obesite
EP3362085C0 (fr) Compositions pour le traitement de maladies impliquant la mucine
HK1221158A1 (zh) 種預防和治療老年癡呆的藥物組合物及其製備方法
MA51688A (fr) Protéines prohémostatiques pour le traitement de saignement
GB201622116D0 (en) Treatment of liver disease
PL3164110T3 (pl) Kompozycje farmaceutyczne do leczenia łuszczycy
HK1259029A1 (zh) 用於治療癌症的具有抗趨除特性的組合物
IL236381A0 (en) Pharmaceutical preparations for the treatment of cancer

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Search report ready

Effective date: 20160729

PLFP Fee payment

Year of fee payment: 3

ST Notification of lapse

Effective date: 20180928